Rhythm Pharmaceuticals, Inc.
RYTM
$59.93
-$0.25-0.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -49.50M | -43.29M | -43.68M | -32.26M | -141.37M |
| Total Depreciation and Amortization | 383.00K | 383.00K | 385.00K | 390.00K | 405.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.67M | 13.86M | 13.38M | 4.94M | 102.41M |
| Change in Net Operating Assets | -7.91M | 10.21M | 4.70M | -2.15M | -2.19M |
| Cash from Operations | -40.35M | -18.85M | -25.22M | -29.08M | -40.74M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.81M | 21.16M | -90.82M | -8.56M | 30.05M |
| Cash from Investing | 24.81M | 21.16M | -90.82M | -8.56M | 30.05M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 37.11M | 42.14M | 5.83M | 1.40M | 7.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 138.85M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.62M | -3.81M | -3.34M | 5.93M | -2.78M |
| Cash from Financing | 32.50M | 38.33M | 2.49M | 146.18M | 4.24M |
| Foreign Exchange rate Adjustments | -2.00K | 977.00K | -603.00K | -301.00K | -71.00K |
| Miscellaneous Cash Flow Adjustments | -- | 1.00K | -1.00K | -- | -- |
| Net Change in Cash | 16.96M | 41.62M | -114.15M | 108.24M | -6.52M |